Pharmafile Logo

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

July 13, 2016 | Communiqué Awards, Lucid 

The winning programme – Treating beyond symptoms in IBD: The Steroid Assessment Tool.

Our approach to medical education is really helping to improve patient outcomes and change lives.

Inflammatory bowel disease (IBD) affects more than 250,000 patients in the UK. Treatment strategies have progressed to treating beyond the symptoms of IBD, aiming to reduce mucosal inflammation, sustain remission and prevent bowel damage. 

Steroids have a place in the treatment pathway but do not sustain remission and are associated with significant side effects.The European Crohn’s and Colitis Organisation (ECCO) defines appropriate steroid use and recommends an exit strategy for steroid-dependent patients. However, gastroenterologists are not aware that inappropriate steroid use occurs in their own clinical practice.

Using a simple digital tool, UK experts audited their own practice and were surprised to see high steroid use among their patients. The expert group became advocates for change, motivated to share their data, targeting more than 300 UK HCPs with high steroid use, which comprises approximately 22% of UK IBD clinicians. Awareness of inappropriate steroid use, and the changes driven by the self-realisation of the need to optimise steroids, have the potential to impact the care delivered to over 50,000 UK IBD patients.


This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

My adventure into the world of Medcomms and Lucid’s Futures Academy

After finishing my PhD, I was disillusioned with the lab. I felt that I wanted more out of my career than working on one protein, in one pathway, for the...

Graduation day is celebrated by Lucid’s third Futures Academy cohort

Lucid’s Futures Academy is proud to release its most recent cohort of graduates into the business for the first of their two rotations.The Futures Academy begins with an eight-week intensive...

Bluedog Launch Celebrations

Teams from all companies within the Lucid Group and Bluedog gathered to celebrate both the launch of this new partnership and Lucid Group’s twelve-year anniversary.  2019 is set to be a...

Lighthouse Medical Communications US appoints Lisa Druce as its new Managing Partner

Lighthouse Medical Communications US, a Lucid Group company, is delighted to announce the appointment of its new Managing Partner, Lisa Druce.Lisa is an experienced strategic business leader and healthcare communications...

Lucid Group brings creative and digital magic to the mix with the acquisition of Bluedog

Lucid Group is delighted to announce its first acquisition, welcoming colleagues from creative and digital consultancy Bluedog into its magic kingdom.Over the last twelve years, Lucid Group has become well...

Lucid Group acquires creative and digital agency Bluedog

Lucid Group is delighted to announce its first acquisition, welcoming colleagues from creative and digital consultancy Bluedog into its magic kingdom.

Lighthouse Medical Communications US goes large in the Big Apple

It’s a double celebration for Lighthouse Medical Communications US, a Lucid Group Company, as it celebrated its four-year anniversary, coupled with a move to impressive new offices in Financial District, Manhattan,...

A dynamic and challenging environment – what it’s like starting a career in MedComms

Ayala Donegan discusses her #LucidLife journey into #MedComms

A Magical Future – A year on from the graduate scheme

Emilie discusses her #LucidLife journey during the past year, after joining Lucid through their graduate scheme.The summer after I graduated from university, I spent a lot of time trying to...